Stocks
ImmunoGen (IMGN) EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -153.5 | -65.7 | -19.7 | -124.2 | -215.8 | -62.8 | ||
| Changes by years, y/y, % | +176% | -57% | -70% | +531% | +74% | +31.2% | |||
ImmunoGen. EBITDA US GAAP, bln rub
ImmunoGen. EBITDA US GAAP, changes, %
ImmunoGen. EBITDA US GAAP, sum by quarters, bln rub
ImmunoGen (IMGN) EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -78.0 | -54.1 | -37.9 | -1.87 | 31.1 | -62.8 | |
| Changes by years, y/y, % | +129% | +56% | +69% | -97% | -140% | |||
| Changes by quarters, q/q, % | +28% | -31% | -30% | -95% | -1 765% | |||
